Behavioral changes as side effects of medication treatment for Parkinson's disease.
Hui
Jennifer S
JS
Department of Neurology, Keck/University of Southern California School of Medicine, Los Angeles, California, USA.
Murdock
Gail A
GA
Chung
Joseph S
JS
Lew
Mark F
MF
D000978:Antiparkinson Agents / Q000009:adverse effects*; D001007:Anxiety / Q000139:chemically induced; D016022:Case-Control Studies; D003071:Cognition / Q000187:drug effects; D003704:Dementia / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D019964:Mood Disorders / Q000139:chemically induced; D020258:Neurotoxicity Syndromes / Q000145:classification / Q000209:etiology*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology*; D012307:Risk Factors; D012893:Sleep Wake Disorders / Q000139:chemically induced
D000978:Antiparkinson Agents